Cargando…
Blood Pressure and Hypertension: Findings from 20 Years of the Tehran Lipid and Glucose Study (TLGS)
CONTEXT: Hypertension (HTN) is a well-known modifiable risk factor for cardiovascular disease (CVD), chronic kidney disease and mortality. Positive effects of blood pressure (BP) lowering for prevention of CVD and death have been documented in several meta-analyses of randomized controlled trials. E...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kowsar
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6289294/ https://www.ncbi.nlm.nih.gov/pubmed/30584437 http://dx.doi.org/10.5812/ijem.84769 |
_version_ | 1783379945556279296 |
---|---|
author | Abdi, Hengameh Amouzegar, Atieh Tohidi, Maryam Azizi, Fereidoun Hadaegh, Farzad |
author_facet | Abdi, Hengameh Amouzegar, Atieh Tohidi, Maryam Azizi, Fereidoun Hadaegh, Farzad |
author_sort | Abdi, Hengameh |
collection | PubMed |
description | CONTEXT: Hypertension (HTN) is a well-known modifiable risk factor for cardiovascular disease (CVD), chronic kidney disease and mortality. Positive effects of blood pressure (BP) lowering for prevention of CVD and death have been documented in several meta-analyses of randomized controlled trials. EVIDENCE ACQUISITION: This review focuses on the key findings derived from the Tehran lipid and glucose study (TLGS) papers on different aspects of BP and HTN. RESULTS: A prevalence of 23% for HTN has been reported in the TLGS population, aged ≥ 20 years. Over a decade long follow-up, the crude incidence rate (95% CI) of new-onset HTN defined as systolic BP (SBP) ≥ 140 mmHg and/or diastolic BP (DBP) ≥ 90 mmHg, and not using antihypertensive medication was 33.63 (32.0 - 35.3) per 1000 person-years. Age, baseline SBP and body mass index were significant risk factors for development of isolated systolic HTN; regarding isolated diastolic HTN, baseline DBP and waist circumference were recognized as important risk factors whereas age, female gender and marriage were shown to be protective factors. SBP decreased significantly in both diabetic and non-diabetic participants; DBP showed a non-significant decrease in diabetic men and a statistically significant decrease in non-diabetic men. Among women, both those with and without diabetes (DM) generally experienced statistically significant decreases in DBP. Cox proportional hazard models showed that neither SBP nor DBP were associated with incident DM in the total population and in either gender, separately. All BP components were associated with CVD and all-cause mortality in the middle-aged population. Contribution of HTN to cerebrovascular events was also documented in the TLGS participants, aged ≥ 50 years. CONCLUSIONS: Several important findings regarding BP/HTN have been derived from the TLGS. According to data regarding the prevalence and incidence of preHTN and HTN and their contribution to cardiovascular morbidity and mortality in the TLGS population as a representative sample of Tehranian population, it is recommended that interventions be prioritized for lifestyle modifications for the prevention and appropriate management of preHTN/HTN. |
format | Online Article Text |
id | pubmed-6289294 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Kowsar |
record_format | MEDLINE/PubMed |
spelling | pubmed-62892942018-12-24 Blood Pressure and Hypertension: Findings from 20 Years of the Tehran Lipid and Glucose Study (TLGS) Abdi, Hengameh Amouzegar, Atieh Tohidi, Maryam Azizi, Fereidoun Hadaegh, Farzad Int J Endocrinol Metab Review Article CONTEXT: Hypertension (HTN) is a well-known modifiable risk factor for cardiovascular disease (CVD), chronic kidney disease and mortality. Positive effects of blood pressure (BP) lowering for prevention of CVD and death have been documented in several meta-analyses of randomized controlled trials. EVIDENCE ACQUISITION: This review focuses on the key findings derived from the Tehran lipid and glucose study (TLGS) papers on different aspects of BP and HTN. RESULTS: A prevalence of 23% for HTN has been reported in the TLGS population, aged ≥ 20 years. Over a decade long follow-up, the crude incidence rate (95% CI) of new-onset HTN defined as systolic BP (SBP) ≥ 140 mmHg and/or diastolic BP (DBP) ≥ 90 mmHg, and not using antihypertensive medication was 33.63 (32.0 - 35.3) per 1000 person-years. Age, baseline SBP and body mass index were significant risk factors for development of isolated systolic HTN; regarding isolated diastolic HTN, baseline DBP and waist circumference were recognized as important risk factors whereas age, female gender and marriage were shown to be protective factors. SBP decreased significantly in both diabetic and non-diabetic participants; DBP showed a non-significant decrease in diabetic men and a statistically significant decrease in non-diabetic men. Among women, both those with and without diabetes (DM) generally experienced statistically significant decreases in DBP. Cox proportional hazard models showed that neither SBP nor DBP were associated with incident DM in the total population and in either gender, separately. All BP components were associated with CVD and all-cause mortality in the middle-aged population. Contribution of HTN to cerebrovascular events was also documented in the TLGS participants, aged ≥ 50 years. CONCLUSIONS: Several important findings regarding BP/HTN have been derived from the TLGS. According to data regarding the prevalence and incidence of preHTN and HTN and their contribution to cardiovascular morbidity and mortality in the TLGS population as a representative sample of Tehranian population, it is recommended that interventions be prioritized for lifestyle modifications for the prevention and appropriate management of preHTN/HTN. Kowsar 2018-10-20 /pmc/articles/PMC6289294/ /pubmed/30584437 http://dx.doi.org/10.5812/ijem.84769 Text en Copyright © 2018, International Journal of Endocrinology and Metabolism http://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited. |
spellingShingle | Review Article Abdi, Hengameh Amouzegar, Atieh Tohidi, Maryam Azizi, Fereidoun Hadaegh, Farzad Blood Pressure and Hypertension: Findings from 20 Years of the Tehran Lipid and Glucose Study (TLGS) |
title | Blood Pressure and Hypertension: Findings from 20 Years of the Tehran Lipid and Glucose Study (TLGS) |
title_full | Blood Pressure and Hypertension: Findings from 20 Years of the Tehran Lipid and Glucose Study (TLGS) |
title_fullStr | Blood Pressure and Hypertension: Findings from 20 Years of the Tehran Lipid and Glucose Study (TLGS) |
title_full_unstemmed | Blood Pressure and Hypertension: Findings from 20 Years of the Tehran Lipid and Glucose Study (TLGS) |
title_short | Blood Pressure and Hypertension: Findings from 20 Years of the Tehran Lipid and Glucose Study (TLGS) |
title_sort | blood pressure and hypertension: findings from 20 years of the tehran lipid and glucose study (tlgs) |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6289294/ https://www.ncbi.nlm.nih.gov/pubmed/30584437 http://dx.doi.org/10.5812/ijem.84769 |
work_keys_str_mv | AT abdihengameh bloodpressureandhypertensionfindingsfrom20yearsofthetehranlipidandglucosestudytlgs AT amouzegaratieh bloodpressureandhypertensionfindingsfrom20yearsofthetehranlipidandglucosestudytlgs AT tohidimaryam bloodpressureandhypertensionfindingsfrom20yearsofthetehranlipidandglucosestudytlgs AT azizifereidoun bloodpressureandhypertensionfindingsfrom20yearsofthetehranlipidandglucosestudytlgs AT hadaeghfarzad bloodpressureandhypertensionfindingsfrom20yearsofthetehranlipidandglucosestudytlgs |